Stocksigma LogoStocksigma Logo

Biogen Pharmachem Shareholders Approve FY26 Financials and Auditor Appointment at AGM

Biogen Pharmachem Industries Limited held its 31st Annual General Meeting on 29th Sep'26, where shareholders approved all key ordinary resolutions

Biogen Pharmachem Shareholders Approve FY26 Financials and Auditor Appointment at AGM

Biogen Pharmachem Industries Ltd 路 Annual General Meeting 路 29 Sept 2026, 11:35 pm

Biogen Pharmachem Shareholders Approve FY26 Financials and Auditor Appointment at AGM Biogen Pharmachem Industries Limited held its 31st Annual General Meeting on 29th Sep'26, where shareholders approved all key ordinary resolutions. Key outcomes include the formal adoption of audited financial statements for the fiscal year ended 31st Mar'26, the re-appointment of retiring director Mr. Kelash Bunkar, and the appointment of M/s. Goenka Mehta & Associates, Chartered Accountants, as the company's new statutory auditors alongside the fixation of their remuneration. Complete voting results under Regulation 44(3) are to be submitted separately.

Original exchange filing (PDF)

More announcements from Biogen Pharmachem Industries Ltd

All Biogen Pharmachem Industries Ltd announcements